Bruells Christian S, Menon Ares K, Rossaint Rolf, Goetzenich Andreas, Czaplik Michael, Zoremba Norbert, Autschbach Rüdiger, Schaelte Gereon
J Cardiothorac Surg. 2013 Jun 24;8:159. doi: 10.1186/1749-8090-8-159.
The Masimo Pronto-7® calculates hemoglobin (Hb) values using the pulsoximetry technique and a variety of mathematical algorithms analyzing the pulse waveform. Although this system has demonstrated a high level of accuracy in average patients, the performance might be altered in special patient populations. Regarding patients with left ventricular cardiac failure, a rotary blood pump generates a constant, continuous, non-pulsatile flow to improve effective cardiac output. Due to this alteration in both, blood flow and arterial blood pressure we hypothesized a reduced accuracy of the Masimo Pronto-7® to detect Hb in patients with left ventricular cardiac failure. To test our hypothesis, we evaluated the Pronto-7®SpHb system in outpatients after continuous-flow-left ventricular assist device (cf-LVAD) implantation (HeartMate II, Thoratec).
21 cf-LVAD outpatients from the Clinic for Cardiac, Thoracic and Vascular Surgery were investigated during routine follow up examinations. After venous blood samples were drawn, the Pronto-7® sensor was attached to one randomly selected finger of one hand. The collected SpHb data were compared with Hb values measured by our central laboratory. The difference between the methods was determined using Bland - Altman analysis. The study was registered in the DRKS (DRKS00004415).
In all cf-LVAD patients evaluated, the Pronto-7® successfully detected SpHb values. Using Bland - Altman analysis, a bias of 0.14 g/dl (95% upper and lower limits of agreement ± 2.76 g/dl) was calculated.
The Pronto-7® overestimated the actual Hb value in cf-LVAD outpatients with the HeartMate II. Due to this, we conclude that the system is suitable for screening in routine examinations and further analysis can be performed if needed. However, its use as an emergency tool is questionable because of the increased inaccuracy when Hb values are critically low.
Masimo Pronto-7® 使用脉搏血氧测定技术和多种分析脉搏波形的数学算法来计算血红蛋白(Hb)值。尽管该系统在一般患者中已显示出较高的准确性,但在特殊患者群体中其性能可能会发生改变。对于左心室心力衰竭患者,旋转式血泵可产生恒定、连续、非搏动性血流以改善有效心输出量。由于血流和动脉血压的这种改变,我们推测Masimo Pronto-7® 在检测左心室心力衰竭患者的Hb时准确性会降低。为验证我们的假设,我们在连续血流左心室辅助装置(cf-LVAD)植入(HeartMate II,Thoratec)后的门诊患者中评估了Pronto-7® SpHb系统。
对来自心脏、胸科和血管外科诊所的21名cf-LVAD门诊患者进行常规随访检查。抽取静脉血样后,将Pronto-7® 传感器连接到一只手的一根随机选择的手指上。将收集到的SpHb数据与我们中心实验室测量的Hb值进行比较。使用Bland - Altman分析确定两种方法之间的差异。该研究已在DRKS(DRKS00004415)注册。
在所有评估的cf-LVAD患者中,Pronto-7® 成功检测到SpHb值。使用Bland - Altman分析,计算出偏差为0.14 g/dl(一致性的95%上下限为±2.76 g/dl)。
Pronto-7® 高估了使用HeartMate II的cf-LVAD门诊患者的实际Hb值。因此,我们得出结论,该系统适用于常规检查中的筛查,如有需要可进行进一步分析。然而,由于在Hb值极低时不准确程度增加,其作为紧急工具的用途存在疑问。